Evidence map›Paper›PMID 37701100›Full record

ArticleTranslational cancer research2023

Dendritic cell vaccination for glioblastoma multiforme patients: has a new milestone been reached?

Stefaan W Van Gool, Jennifer Makalowski, Linde F C Kampers, Peter Van de Vliet, Tobias Sprenger, Volker Schirrmacher, Wilfried Stücker

Open access · diamondAbstract readEditorialComment
In one paragraph

Article in Translational cancer research, 2023. The graph could read no effect estimate from its abstract, so it casts no vote on the map. Cited by 11 papers, 1 of them a synthesis that pooled it.

0numbers the graph read from it
0cells of the map it votes in
11citing papers in PubMed, 1 pooled it
2.3field-weighted citation impact, top 11% of its field
1 · What the graph read from it

What it found

Each row is one number read from the abstract, on the scale the paper reported it, with its interval. Left of the dashed line favours the treatment, right favours the comparator. Under each row is the sentence it came from. New to these charts? A ten-minute tutorial.

The abstract states no effect estimate the extractor could read, or names no intervention and outcome on the map, so this paper lights no cell and moves no belief. It is still indexed, cited and linked below.

2 · The registry

The trial behind it

Trials whose registry record cites this paper, or whose number appears in the abstract. A trial that started after this paper was published is citing it as background, not reporting it.

Neither the registry nor the abstract names a trial number. If this is a trial report, that itself is worth knowing.

3 · Its place in the literature

Who cites it

11 citing papers in PubMed, 1 synthesis or guideline pooled it, 14 citations in OpenAlex.

  1. Autologous tumor lysate-loaded dendritic cell vaccination in glioblastoma patients: a systematic review of literature.Clinical & translational oncology : official publication of the Federation of Spanish Oncology Societies and of the National Cancer Institute of Mexico · 2025
    Pooled it
  2. Article
  3. Article
  4. Review
  5. Article
  6. Review
  7. Review
  8. Updates in Immunotherapy for Pancreatic Cancer.Journal of clinical medicine · 2024
    Review
  9. Review
  10. Review
  11. Review
4 · The record

Corrections and comments

5 · Who and what money

Authors and funding

7 authors at 1 institution in 1 country.

Stefaan W Van GoolImmun-Onkologisches Zentrum Köln, Köln, Germany.
Jennifer MakalowskiImmun-Onkologisches Zentrum Köln, Köln, Germany.
Linde F C KampersImmun-Onkologisches Zentrum Köln, Köln, Germany.
Peter Van de VlietImmun-Onkologisches Zentrum Köln, Köln, Germany.
Tobias SprengerImmun-Onkologisches Zentrum Köln, Köln, Germany.
Volker SchirrmacherImmun-Onkologisches Zentrum Köln, Köln, Germany.
Wilfried StückerImmun-Onkologisches Zentrum Köln, Köln, Germany.
Centrum für Integrierte Onkologie · DE

Funding

No grant is acknowledged in the PubMed record.

6 · The paper itself

Abstract

PubMed holds no abstract for this paper.

Indexed as

DCVax®-Ldendritic cell vaccines (DC vaccines)external control arm (ECA)Glioblastomaindividualized multimodal immunotherapy (IMI)

Identifiers

PMID37701100
PMCPMC10493805
OpenAlexW4386170759

What OpenQuestion holds

Textmetadata
LicenceCC BY-NC-ND
Read underepoch 390

Registered trials

None linked

Read under generation 80e0d062 · epoch 390. Bibliography from PubMed, PubMed Central and OpenAlex; grants from NIH RePORTER; trial links from ClinicalTrials.gov; estimates, votes and beliefs from the OpenQuestion graph.